Los Angeles Biotech Trending News

Bristol Myers’ lead deal negotiator to depart after inking series of multibillion-dollar acquisitions

Elizabeth Mily, the lead acquisition and deal negotiator at Bristol Myers Squibb, is leaving the Big Pharma, a spokesperson confirmed to Endpoints News on Friday morning. Since joining Bristol Myers in the spring of 2020 […]


Graphite Bio divests gene editing pipeline to newly-formed Kamau Therapeutics after announcing reverse merger with Lenz Therapeutics

Kamau Therapeutics has emerged from stealth mode after inking a deal with Graphite Bio for its genome editing assets. Kamau’s debut comes less than a month after Graphite entered a reverse merger deal with Lenz […]


Ex-Cedilla CEO Glucksmann explores ‘new frontier’ at Sensorium; R&D chief out at Merck women’s health spinoff Organon

Alexandra Glucksmann Alexandra Glucksmann is always looking for “the next frontier” in medicine. After spending most of her career in genetic diseases, rare diseases and oncology, her next pursuit is in mental health. The longtime […]


MBrace Therapeutics Presents Preclinical Data Demonstrating Potential of Novel Antibody Drug Conjugate at 2023 San Antonio Breast Cancer Symposium

SAN DIEGO–(BUSINESS WIRE)–MBrace Therapeutics, Inc. (“MBrace”), a clinical-stage biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets, today announced new preclinical data supporting […]